CAMP4 THERAPEUTICS CORPORATION (CAMP)

CAMP4 THERAPEUTICS CORPORATION (CAMP) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $215M; returns 1 day -2.7%, 1 week +4.1%, 1 year -5.2%.

CAMP4 Therapeutics Corporation (Nasdaq: CAMP) is a clinical-stage biopharmaceutical company focused on developing regulatory RNA-targeting therapeutics, specifically antisense oligonucleotide (ASO)-based therapies, to upregulate gene expression and restore healthy protein levels for a broad range of genetic diseases.

Groups CAMP belongs to

• Biotechnology
• Clinical Stage Biotech
• Healthcare
• Biopharmaceutical
• Rare Diseases
• Gene Therapy
• Clinical Stage
• Drug Discovery
• Neuroscience
• CNS Disorders
• Strategic Partnerships

CAMP financial model: income statement, cash flow and balance sheet